Barclays Starts Moderna (MRNA) at Overweight
Tweet
Share
E-mail
Get Alerts MRNA Hot Sheet
Price: $63.32 -0.52%
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays analyst Gena Wang initiates coverage on Moderna (NASDAQ: MRNA) with a Overweight rating and a price target of $68.00.
For an analyst ratings summary and ratings history on Moderna click here. For more ratings news on Moderna click here.
Shares of Moderna closed at $56.40 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- Barclays Downgrades PolyPeptide Group AG (PPGN:SW) to Equalweight
- Jefferies Starts Aehr Test Systems (AEHR) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Barclays, Gena WangSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
